nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—asthma—atopic dermatitis	0.74	1	CtDrD
Zileuton—PTGS1—Diphenhydramine—atopic dermatitis	0.0436	0.223	CbGbCtD
Zileuton—CYP3A4—Pimecrolimus—atopic dermatitis	0.0234	0.12	CbGbCtD
Zileuton—CYP1A2—Diphenhydramine—atopic dermatitis	0.0195	0.0998	CbGbCtD
Zileuton—CYP2C9—Loratadine—atopic dermatitis	0.0175	0.0899	CbGbCtD
Zileuton—CYP2C9—Diphenhydramine—atopic dermatitis	0.0175	0.0899	CbGbCtD
Zileuton—CYP3A4—Tacrolimus—atopic dermatitis	0.0139	0.0714	CbGbCtD
Zileuton—CYP3A4—Loratadine—atopic dermatitis	0.0102	0.0523	CbGbCtD
Zileuton—CYP3A4—Methylprednisolone—atopic dermatitis	0.00932	0.0478	CbGbCtD
Zileuton—CYP3A4—Triamcinolone—atopic dermatitis	0.00707	0.0362	CbGbCtD
Zileuton—CYP2C9—Dexamethasone—atopic dermatitis	0.00607	0.0311	CbGbCtD
Zileuton—CYP3A4—Betamethasone—atopic dermatitis	0.00606	0.0311	CbGbCtD
Zileuton—CYP3A4—Prednisolone—atopic dermatitis	0.00598	0.0307	CbGbCtD
Zileuton—CYP3A4—Hydrocortisone—atopic dermatitis	0.00567	0.0291	CbGbCtD
Zileuton—CYP3A4—Prednisone—atopic dermatitis	0.00565	0.029	CbGbCtD
Zileuton—CYP3A4—Dexamethasone—atopic dermatitis	0.00353	0.0181	CbGbCtD
Zileuton—Chest pain—Loratadine—atopic dermatitis	0.000298	0.0051	CcSEcCtD
Zileuton—Myalgia—Loratadine—atopic dermatitis	0.000298	0.0051	CcSEcCtD
Zileuton—Conjunctivitis—Tacrolimus—atopic dermatitis	0.000298	0.00508	CcSEcCtD
Zileuton—Urinary tract infection—Tacrolimus—atopic dermatitis	0.000298	0.00508	CcSEcCtD
Zileuton—Urticaria—Dimenhydrinate—atopic dermatitis	0.000295	0.00504	CcSEcCtD
Zileuton—Urticaria—Diphenhydramine—atopic dermatitis	0.000295	0.00504	CcSEcCtD
Zileuton—Discomfort—Loratadine—atopic dermatitis	0.000295	0.00503	CcSEcCtD
Zileuton—Pruritus—Fluocinonide—atopic dermatitis	0.000291	0.00498	CcSEcCtD
Zileuton—Sinusitis—Tacrolimus—atopic dermatitis	0.000287	0.00491	CcSEcCtD
Zileuton—Urticaria—Pimecrolimus—atopic dermatitis	0.000285	0.00487	CcSEcCtD
Zileuton—Body temperature increased—Pimecrolimus—atopic dermatitis	0.000284	0.00485	CcSEcCtD
Zileuton—Hepatitis—Tacrolimus—atopic dermatitis	0.000275	0.0047	CcSEcCtD
Zileuton—Dizziness—Fluocinonide—atopic dermatitis	0.000272	0.00465	CcSEcCtD
Zileuton—Arthralgia—Fluocinolone Acetonide—atopic dermatitis	0.000268	0.00458	CcSEcCtD
Zileuton—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000264	0.00452	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.00026	0.00445	CcSEcCtD
Zileuton—Rash—Fluocinonide—atopic dermatitis	0.00026	0.00443	CcSEcCtD
Zileuton—Dermatitis—Fluocinonide—atopic dermatitis	0.000259	0.00443	CcSEcCtD
Zileuton—Insomnia—Loratadine—atopic dermatitis	0.000259	0.00442	CcSEcCtD
Zileuton—Headache—Fluocinonide—atopic dermatitis	0.000258	0.00441	CcSEcCtD
Zileuton—Arthralgia—Mometasone—atopic dermatitis	0.000256	0.00437	CcSEcCtD
Zileuton—Chest pain—Mometasone—atopic dermatitis	0.000256	0.00437	CcSEcCtD
Zileuton—Myalgia—Mometasone—atopic dermatitis	0.000256	0.00437	CcSEcCtD
Zileuton—Somnolence—Loratadine—atopic dermatitis	0.000254	0.00434	CcSEcCtD
Zileuton—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000254	0.00434	CcSEcCtD
Zileuton—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000254	0.00434	CcSEcCtD
Zileuton—Pruritus—Pimecrolimus—atopic dermatitis	0.000254	0.00434	CcSEcCtD
Zileuton—Dyspepsia—Loratadine—atopic dermatitis	0.000252	0.0043	CcSEcCtD
Zileuton—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000247	0.00422	CcSEcCtD
Zileuton—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000246	0.0042	CcSEcCtD
Zileuton—Dizziness—Dimenhydrinate—atopic dermatitis	0.000245	0.00419	CcSEcCtD
Zileuton—Dizziness—Diphenhydramine—atopic dermatitis	0.000245	0.00419	CcSEcCtD
Zileuton—Pain—Loratadine—atopic dermatitis	0.000244	0.00418	CcSEcCtD
Zileuton—Constipation—Loratadine—atopic dermatitis	0.000244	0.00418	CcSEcCtD
Zileuton—Vomiting—Dimenhydrinate—atopic dermatitis	0.000236	0.00403	CcSEcCtD
Zileuton—Vomiting—Diphenhydramine—atopic dermatitis	0.000236	0.00403	CcSEcCtD
Zileuton—Flatulence—Tacrolimus—atopic dermatitis	0.000236	0.00403	CcSEcCtD
Zileuton—Feeling abnormal—Loratadine—atopic dermatitis	0.000236	0.00402	CcSEcCtD
Zileuton—Tension—Tacrolimus—atopic dermatitis	0.000235	0.00401	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000234	0.004	CcSEcCtD
Zileuton—Rash—Dimenhydrinate—atopic dermatitis	0.000234	0.004	CcSEcCtD
Zileuton—Rash—Diphenhydramine—atopic dermatitis	0.000234	0.004	CcSEcCtD
Zileuton—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000234	0.00399	CcSEcCtD
Zileuton—Dermatitis—Diphenhydramine—atopic dermatitis	0.000234	0.00399	CcSEcCtD
Zileuton—Headache—Dimenhydrinate—atopic dermatitis	0.000233	0.00397	CcSEcCtD
Zileuton—Headache—Diphenhydramine—atopic dermatitis	0.000233	0.00397	CcSEcCtD
Zileuton—Nervousness—Tacrolimus—atopic dermatitis	0.000232	0.00397	CcSEcCtD
Zileuton—Vomiting—Pimecrolimus—atopic dermatitis	0.000228	0.0039	CcSEcCtD
Zileuton—Abdominal pain upper—Hydrocortisone—atopic dermatitis	0.000226	0.00387	CcSEcCtD
Zileuton—Rash—Pimecrolimus—atopic dermatitis	0.000226	0.00387	CcSEcCtD
Zileuton—Dermatitis—Pimecrolimus—atopic dermatitis	0.000226	0.00386	CcSEcCtD
Zileuton—Body temperature increased—Loratadine—atopic dermatitis	0.000226	0.00386	CcSEcCtD
Zileuton—Headache—Pimecrolimus—atopic dermatitis	0.000225	0.00384	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000224	0.00382	CcSEcCtD
Zileuton—Ill-defined disorder—Tacrolimus—atopic dermatitis	0.000222	0.00379	CcSEcCtD
Zileuton—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000222	0.00379	CcSEcCtD
Zileuton—Nausea—Dimenhydrinate—atopic dermatitis	0.00022	0.00377	CcSEcCtD
Zileuton—Nausea—Diphenhydramine—atopic dermatitis	0.00022	0.00377	CcSEcCtD
Zileuton—Pain—Fluocinolone Acetonide—atopic dermatitis	0.00022	0.00375	CcSEcCtD
Zileuton—Dyspepsia—Mometasone—atopic dermatitis	0.000216	0.00369	CcSEcCtD
Zileuton—Malaise—Tacrolimus—atopic dermatitis	0.000216	0.00369	CcSEcCtD
Zileuton—Nausea—Pimecrolimus—atopic dermatitis	0.000213	0.00364	CcSEcCtD
Zileuton—Pain—Mometasone—atopic dermatitis	0.00021	0.00358	CcSEcCtD
Zileuton—Arthralgia—Tacrolimus—atopic dermatitis	0.000204	0.00348	CcSEcCtD
Zileuton—Myalgia—Tacrolimus—atopic dermatitis	0.000204	0.00348	CcSEcCtD
Zileuton—Chest pain—Tacrolimus—atopic dermatitis	0.000204	0.00348	CcSEcCtD
Zileuton—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000203	0.00347	CcSEcCtD
Zileuton—Discomfort—Tacrolimus—atopic dermatitis	0.000201	0.00344	CcSEcCtD
Zileuton—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000199	0.0034	CcSEcCtD
Zileuton—Diarrhoea—Loratadine—atopic dermatitis	0.000196	0.00334	CcSEcCtD
Zileuton—Body temperature increased—Mometasone—atopic dermatitis	0.000194	0.00331	CcSEcCtD
Zileuton—Conjunctivitis—Prednisolone—atopic dermatitis	0.00019	0.00325	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00019	0.0283	CbGpPWpGaD
Zileuton—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000189	0.00323	CcSEcCtD
Zileuton—Dizziness—Loratadine—atopic dermatitis	0.000189	0.00323	CcSEcCtD
Zileuton—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000187	0.0032	CcSEcCtD
Zileuton—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000182	0.00311	CcSEcCtD
Zileuton—Vomiting—Loratadine—atopic dermatitis	0.000182	0.00311	CcSEcCtD
Zileuton—Rash—Loratadine—atopic dermatitis	0.00018	0.00308	CcSEcCtD
Zileuton—Dermatitis—Loratadine—atopic dermatitis	0.00018	0.00308	CcSEcCtD
Zileuton—Headache—Loratadine—atopic dermatitis	0.000179	0.00306	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000178	0.00304	CcSEcCtD
Zileuton—Insomnia—Tacrolimus—atopic dermatitis	0.000177	0.00302	CcSEcCtD
Zileuton—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000176	0.003	CcSEcCtD
Zileuton—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000175	0.00299	CcSEcCtD
Zileuton—Somnolence—Tacrolimus—atopic dermatitis	0.000174	0.00297	CcSEcCtD
Zileuton—Pruritus—Mometasone—atopic dermatitis	0.000174	0.00297	CcSEcCtD
Zileuton—Dyspepsia—Tacrolimus—atopic dermatitis	0.000172	0.00294	CcSEcCtD
Zileuton—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00017	0.0029	CcSEcCtD
Zileuton—Nausea—Loratadine—atopic dermatitis	0.00017	0.0029	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000169	0.0252	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000169	0.00288	CcSEcCtD
Zileuton—Diarrhoea—Mometasone—atopic dermatitis	0.000168	0.00287	CcSEcCtD
Zileuton—Pain—Tacrolimus—atopic dermatitis	0.000167	0.00285	CcSEcCtD
Zileuton—Constipation—Tacrolimus—atopic dermatitis	0.000167	0.00285	CcSEcCtD
Zileuton—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000163	0.00279	CcSEcCtD
Zileuton—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000162	0.00277	CcSEcCtD
Zileuton—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000162	0.00277	CcSEcCtD
Zileuton—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000161	0.00275	CcSEcCtD
Zileuton—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000161	0.00275	CcSEcCtD
Zileuton—Conjunctivitis—Betamethasone—atopic dermatitis	0.000159	0.00271	CcSEcCtD
Zileuton—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000159	0.00271	CcSEcCtD
Zileuton—Vomiting—Mometasone—atopic dermatitis	0.000156	0.00267	CcSEcCtD
Zileuton—Urticaria—Tacrolimus—atopic dermatitis	0.000155	0.00265	CcSEcCtD
Zileuton—Rash—Mometasone—atopic dermatitis	0.000155	0.00264	CcSEcCtD
Zileuton—Dermatitis—Mometasone—atopic dermatitis	0.000155	0.00264	CcSEcCtD
Zileuton—Body temperature increased—Tacrolimus—atopic dermatitis	0.000154	0.00264	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000154	0.0229	CbGpPWpGaD
Zileuton—Headache—Mometasone—atopic dermatitis	0.000154	0.00263	CcSEcCtD
Zileuton—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000153	0.00261	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000152	0.0226	CbGpPWpGaD
Zileuton—Nausea—Mometasone—atopic dermatitis	0.000146	0.00249	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL22—atopic dermatitis	0.000145	0.0215	CbGpPWpGaD
Zileuton—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000144	0.00246	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000142	0.00242	CcSEcCtD
Zileuton—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000138	0.00237	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—BDNF—atopic dermatitis	0.000138	0.0206	CbGpPWpGaD
Zileuton—Pruritus—Tacrolimus—atopic dermatitis	0.000138	0.00236	CcSEcCtD
Zileuton—Malaise—Prednisolone—atopic dermatitis	0.000138	0.00235	CcSEcCtD
Zileuton—Malaise—Hydrocortisone—atopic dermatitis	0.000135	0.0023	CcSEcCtD
Zileuton—LTB4R—G alpha (q) signalling events—NPS—atopic dermatitis	0.000134	0.02	CbGpPWpGaD
Zileuton—LTB4R—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000134	0.02	CbGpPWpGaD
Zileuton—Diarrhoea—Tacrolimus—atopic dermatitis	0.000134	0.00228	CcSEcCtD
Zileuton—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.00013	0.00223	CcSEcCtD
Zileuton—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.00013	0.00222	CcSEcCtD
Zileuton—Dizziness—Tacrolimus—atopic dermatitis	0.000129	0.00221	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL27—atopic dermatitis	0.000129	0.0192	CbGpPWpGaD
Zileuton—Discomfort—Prednisolone—atopic dermatitis	0.000129	0.0022	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IL4—atopic dermatitis	0.000128	0.0191	CbGpPWpGaD
Zileuton—Myalgia—Hydrocortisone—atopic dermatitis	0.000127	0.00217	CcSEcCtD
Zileuton—Malaise—Triamcinolone—atopic dermatitis	0.000127	0.00217	CcSEcCtD
Zileuton—Malaise—Methylprednisolone—atopic dermatitis	0.000126	0.00216	CcSEcCtD
Zileuton—Discomfort—Hydrocortisone—atopic dermatitis	0.000126	0.00214	CcSEcCtD
Zileuton—Vomiting—Tacrolimus—atopic dermatitis	0.000124	0.00212	CcSEcCtD
Zileuton—Rash—Tacrolimus—atopic dermatitis	0.000123	0.0021	CcSEcCtD
Zileuton—Dermatitis—Tacrolimus—atopic dermatitis	0.000123	0.0021	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000122	0.0182	CbGpPWpGaD
Zileuton—Headache—Tacrolimus—atopic dermatitis	0.000122	0.00209	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00012	0.0179	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00012	0.0179	CbGpPWpGaD
Zileuton—Myalgia—Triamcinolone—atopic dermatitis	0.00012	0.00204	CcSEcCtD
Zileuton—Arthralgia—Methylprednisolone—atopic dermatitis	0.000119	0.00204	CcSEcCtD
Zileuton—Myalgia—Methylprednisolone—atopic dermatitis	0.000119	0.00204	CcSEcCtD
Zileuton—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000118	0.00202	CcSEcCtD
Zileuton—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000118	0.00202	CcSEcCtD
Zileuton—Discomfort—Triamcinolone—atopic dermatitis	0.000118	0.00202	CcSEcCtD
Zileuton—Discomfort—Methylprednisolone—atopic dermatitis	0.000118	0.00202	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000116	0.0173	CbGpPWpGaD
Zileuton—Nausea—Tacrolimus—atopic dermatitis	0.000116	0.00198	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL17—atopic dermatitis	0.000116	0.0172	CbGpPWpGaD
Zileuton—Malaise—Betamethasone—atopic dermatitis	0.000115	0.00196	CcSEcCtD
Zileuton—Malaise—Dexamethasone—atopic dermatitis	0.000115	0.00196	CcSEcCtD
Zileuton—UGT1A9—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.000113	0.0169	CbGpPWpGaD
Zileuton—Insomnia—Prednisolone—atopic dermatitis	0.000113	0.00193	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000111	0.0019	CcSEcCtD
Zileuton—Insomnia—Hydrocortisone—atopic dermatitis	0.00011	0.00188	CcSEcCtD
Zileuton—Myalgia—Dexamethasone—atopic dermatitis	0.000109	0.00185	CcSEcCtD
Zileuton—Myalgia—Betamethasone—atopic dermatitis	0.000109	0.00185	CcSEcCtD
Zileuton—Discomfort—Betamethasone—atopic dermatitis	0.000107	0.00183	CcSEcCtD
Zileuton—Discomfort—Dexamethasone—atopic dermatitis	0.000107	0.00183	CcSEcCtD
Zileuton—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000107	0.00183	CcSEcCtD
Zileuton—Pain—Prednisolone—atopic dermatitis	0.000107	0.00182	CcSEcCtD
Zileuton—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000105	0.0018	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000104	0.00179	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000104	0.00178	CcSEcCtD
Zileuton—Pain—Hydrocortisone—atopic dermatitis	0.000104	0.00178	CcSEcCtD
Zileuton—Insomnia—Triamcinolone—atopic dermatitis	0.000104	0.00177	CcSEcCtD
Zileuton—Insomnia—Methylprednisolone—atopic dermatitis	0.000103	0.00177	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisone—atopic dermatitis	0.000103	0.00176	CcSEcCtD
Zileuton—Feeling abnormal—Prednisolone—atopic dermatitis	0.000103	0.00176	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000102	0.0152	CbGpPWpGaD
Zileuton—Dyspepsia—Triamcinolone—atopic dermatitis	0.000101	0.00172	CcSEcCtD
Zileuton—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000101	0.00172	CcSEcCtD
Zileuton—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.0001	0.00171	CcSEcCtD
Zileuton—Malaise—Prednisone—atopic dermatitis	0.0001	0.00171	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.0001	0.0149	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	9.98e-05	0.0149	CbGpPWpGaD
Zileuton—Urticaria—Prednisolone—atopic dermatitis	9.91e-05	0.00169	CcSEcCtD
Zileuton—Pain—Triamcinolone—atopic dermatitis	9.81e-05	0.00168	CcSEcCtD
Zileuton—Urticaria—Hydrocortisone—atopic dermatitis	9.68e-05	0.00165	CcSEcCtD
Zileuton—Body temperature increased—Hydrocortisone—atopic dermatitis	9.63e-05	0.00165	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	9.48e-05	0.00162	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	9.48e-05	0.00162	CcSEcCtD
Zileuton—Myalgia—Prednisone—atopic dermatitis	9.45e-05	0.00162	CcSEcCtD
Zileuton—Arthralgia—Prednisone—atopic dermatitis	9.45e-05	0.00162	CcSEcCtD
Zileuton—Feeling abnormal—Triamcinolone—atopic dermatitis	9.45e-05	0.00161	CcSEcCtD
Zileuton—Feeling abnormal—Methylprednisolone—atopic dermatitis	9.43e-05	0.00161	CcSEcCtD
Zileuton—Insomnia—Dexamethasone—atopic dermatitis	9.41e-05	0.00161	CcSEcCtD
Zileuton—Insomnia—Betamethasone—atopic dermatitis	9.41e-05	0.00161	CcSEcCtD
Zileuton—Discomfort—Prednisone—atopic dermatitis	9.34e-05	0.0016	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL11—atopic dermatitis	9.32e-05	0.0139	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisolone—atopic dermatitis	9.19e-05	0.00157	CcSEcCtD
Zileuton—Dyspepsia—Betamethasone—atopic dermatitis	9.16e-05	0.00157	CcSEcCtD
Zileuton—Dyspepsia—Dexamethasone—atopic dermatitis	9.16e-05	0.00157	CcSEcCtD
Zileuton—Urticaria—Triamcinolone—atopic dermatitis	9.11e-05	0.00156	CcSEcCtD
Zileuton—Urticaria—Methylprednisolone—atopic dermatitis	9.09e-05	0.00155	CcSEcCtD
Zileuton—Body temperature increased—Triamcinolone—atopic dermatitis	9.07e-05	0.00155	CcSEcCtD
Zileuton—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.98e-05	0.00154	CcSEcCtD
Zileuton—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.98e-05	0.00154	CcSEcCtD
Zileuton—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.97e-05	0.00153	CcSEcCtD
Zileuton—Pain—Betamethasone—atopic dermatitis	8.9e-05	0.00152	CcSEcCtD
Zileuton—Pain—Dexamethasone—atopic dermatitis	8.9e-05	0.00152	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	8.89e-05	0.0132	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	8.89e-05	0.0132	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	8.72e-05	0.013	CbGpPWpGaD
Zileuton—Pruritus—Hydrocortisone—atopic dermatitis	8.62e-05	0.00147	CcSEcCtD
Zileuton—Feeling abnormal—Betamethasone—atopic dermatitis	8.58e-05	0.00147	CcSEcCtD
Zileuton—Feeling abnormal—Dexamethasone—atopic dermatitis	8.58e-05	0.00147	CcSEcCtD
Zileuton—Hypersensitivity—Triamcinolone—atopic dermatitis	8.45e-05	0.00144	CcSEcCtD
Zileuton—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.43e-05	0.00144	CcSEcCtD
Zileuton—Diarrhoea—Hydrocortisone—atopic dermatitis	8.33e-05	0.00142	CcSEcCtD
Zileuton—Urticaria—Dexamethasone—atopic dermatitis	8.27e-05	0.00141	CcSEcCtD
Zileuton—Urticaria—Betamethasone—atopic dermatitis	8.27e-05	0.00141	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Prednisone—atopic dermatitis	8.26e-05	0.00141	CcSEcCtD
Zileuton—Dizziness—Prednisolone—atopic dermatitis	8.25e-05	0.00141	CcSEcCtD
Zileuton—Body temperature increased—Betamethasone—atopic dermatitis	8.23e-05	0.00141	CcSEcCtD
Zileuton—Body temperature increased—Dexamethasone—atopic dermatitis	8.23e-05	0.00141	CcSEcCtD
Zileuton—Insomnia—Prednisone—atopic dermatitis	8.2e-05	0.0014	CcSEcCtD
Zileuton—Pruritus—Triamcinolone—atopic dermatitis	8.11e-05	0.00139	CcSEcCtD
Zileuton—Pruritus—Methylprednisolone—atopic dermatitis	8.1e-05	0.00138	CcSEcCtD
Zileuton—Dizziness—Hydrocortisone—atopic dermatitis	8.05e-05	0.00138	CcSEcCtD
Zileuton—Dyspepsia—Prednisone—atopic dermatitis	7.98e-05	0.00136	CcSEcCtD
Zileuton—Rash—Prednisolone—atopic dermatitis	7.86e-05	0.00134	CcSEcCtD
Zileuton—Dermatitis—Prednisolone—atopic dermatitis	7.86e-05	0.00134	CcSEcCtD
Zileuton—Diarrhoea—Methylprednisolone—atopic dermatitis	7.83e-05	0.00134	CcSEcCtD
Zileuton—Headache—Prednisolone—atopic dermatitis	7.81e-05	0.00133	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IFNG—atopic dermatitis	7.76e-05	0.0115	CbGpPWpGaD
Zileuton—Constipation—Prednisone—atopic dermatitis	7.75e-05	0.00132	CcSEcCtD
Zileuton—Vomiting—Hydrocortisone—atopic dermatitis	7.74e-05	0.00132	CcSEcCtD
Zileuton—Rash—Hydrocortisone—atopic dermatitis	7.68e-05	0.00131	CcSEcCtD
Zileuton—Dermatitis—Hydrocortisone—atopic dermatitis	7.67e-05	0.00131	CcSEcCtD
Zileuton—Headache—Hydrocortisone—atopic dermatitis	7.63e-05	0.0013	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCR3—atopic dermatitis	7.6e-05	0.0113	CbGpPWpGaD
Zileuton—Dizziness—Triamcinolone—atopic dermatitis	7.58e-05	0.0013	CcSEcCtD
Zileuton—Dizziness—Methylprednisolone—atopic dermatitis	7.57e-05	0.00129	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	7.5e-05	0.0112	CbGpPWpGaD
Zileuton—Feeling abnormal—Prednisone—atopic dermatitis	7.47e-05	0.00128	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CCL22—atopic dermatitis	7.42e-05	0.0111	CbGpPWpGaD
Zileuton—Nausea—Prednisolone—atopic dermatitis	7.41e-05	0.00127	CcSEcCtD
Zileuton—Pruritus—Dexamethasone—atopic dermatitis	7.36e-05	0.00126	CcSEcCtD
Zileuton—Pruritus—Betamethasone—atopic dermatitis	7.36e-05	0.00126	CcSEcCtD
Zileuton—Vomiting—Triamcinolone—atopic dermatitis	7.29e-05	0.00125	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CCL27—atopic dermatitis	7.28e-05	0.0108	CbGpPWpGaD
Zileuton—Vomiting—Methylprednisolone—atopic dermatitis	7.28e-05	0.00124	CcSEcCtD
Zileuton—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	7.24e-05	0.0108	CbGpPWpGaD
Zileuton—Nausea—Hydrocortisone—atopic dermatitis	7.23e-05	0.00124	CcSEcCtD
Zileuton—Rash—Triamcinolone—atopic dermatitis	7.23e-05	0.00124	CcSEcCtD
Zileuton—Dermatitis—Triamcinolone—atopic dermatitis	7.22e-05	0.00123	CcSEcCtD
Zileuton—Rash—Methylprednisolone—atopic dermatitis	7.22e-05	0.00123	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—CXCL8—atopic dermatitis	7.21e-05	0.0107	CbGpPWpGaD
Zileuton—Dermatitis—Methylprednisolone—atopic dermatitis	7.21e-05	0.00123	CcSEcCtD
Zileuton—Urticaria—Prednisone—atopic dermatitis	7.2e-05	0.00123	CcSEcCtD
Zileuton—Headache—Triamcinolone—atopic dermatitis	7.18e-05	0.00123	CcSEcCtD
Zileuton—Headache—Methylprednisolone—atopic dermatitis	7.17e-05	0.00122	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—atopic dermatitis	7.16e-05	0.00122	CcSEcCtD
Zileuton—Diarrhoea—Dexamethasone—atopic dermatitis	7.12e-05	0.00122	CcSEcCtD
Zileuton—Diarrhoea—Betamethasone—atopic dermatitis	7.12e-05	0.00122	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	7.05e-05	0.0105	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL1B—atopic dermatitis	6.92e-05	0.0103	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL2—atopic dermatitis	6.89e-05	0.0103	CbGpPWpGaD
Zileuton—Dizziness—Dexamethasone—atopic dermatitis	6.88e-05	0.00118	CcSEcCtD
Zileuton—Dizziness—Betamethasone—atopic dermatitis	6.88e-05	0.00118	CcSEcCtD
Zileuton—Nausea—Triamcinolone—atopic dermatitis	6.81e-05	0.00116	CcSEcCtD
Zileuton—Nausea—Methylprednisolone—atopic dermatitis	6.8e-05	0.00116	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—TAC1—atopic dermatitis	6.77e-05	0.0101	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—NPS—atopic dermatitis	6.77e-05	0.0101	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisone—atopic dermatitis	6.68e-05	0.00114	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCR3—atopic dermatitis	6.64e-05	0.00989	CbGpPWpGaD
Zileuton—Vomiting—Betamethasone—atopic dermatitis	6.62e-05	0.00113	CcSEcCtD
Zileuton—Vomiting—Dexamethasone—atopic dermatitis	6.62e-05	0.00113	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CCL27—atopic dermatitis	6.61e-05	0.00985	CbGpPWpGaD
Zileuton—Rash—Betamethasone—atopic dermatitis	6.56e-05	0.00112	CcSEcCtD
Zileuton—Rash—Dexamethasone—atopic dermatitis	6.56e-05	0.00112	CcSEcCtD
Zileuton—Dermatitis—Dexamethasone—atopic dermatitis	6.56e-05	0.00112	CcSEcCtD
Zileuton—Dermatitis—Betamethasone—atopic dermatitis	6.56e-05	0.00112	CcSEcCtD
Zileuton—Headache—Betamethasone—atopic dermatitis	6.52e-05	0.00111	CcSEcCtD
Zileuton—Headache—Dexamethasone—atopic dermatitis	6.52e-05	0.00111	CcSEcCtD
Zileuton—Pruritus—Prednisone—atopic dermatitis	6.41e-05	0.0011	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	6.38e-05	0.0095	CbGpPWpGaD
Zileuton—Diarrhoea—Prednisone—atopic dermatitis	6.2e-05	0.00106	CcSEcCtD
Zileuton—Nausea—Betamethasone—atopic dermatitis	6.18e-05	0.00106	CcSEcCtD
Zileuton—Nausea—Dexamethasone—atopic dermatitis	6.18e-05	0.00106	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	6.07e-05	0.00903	CbGpPWpGaD
Zileuton—Dizziness—Prednisone—atopic dermatitis	5.99e-05	0.00102	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CCL17—atopic dermatitis	5.93e-05	0.00883	CbGpPWpGaD
Zileuton—Vomiting—Prednisone—atopic dermatitis	5.76e-05	0.000985	CcSEcCtD
Zileuton—Rash—Prednisone—atopic dermatitis	5.71e-05	0.000976	CcSEcCtD
Zileuton—Dermatitis—Prednisone—atopic dermatitis	5.71e-05	0.000975	CcSEcCtD
Zileuton—Headache—Prednisone—atopic dermatitis	5.68e-05	0.00097	CcSEcCtD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.57e-05	0.00829	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.47e-05	0.00814	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IFNG—atopic dermatitis	5.46e-05	0.00812	CbGpPWpGaD
Zileuton—Nausea—Prednisone—atopic dermatitis	5.38e-05	0.00092	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCL10—atopic dermatitis	5.37e-05	0.00799	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	5.22e-05	0.00777	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—TNF—atopic dermatitis	5.02e-05	0.00747	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	4.88e-05	0.00726	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL1B—atopic dermatitis	4.87e-05	0.00725	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL11—atopic dermatitis	4.78e-05	0.00712	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—FCER2—atopic dermatitis	4.72e-05	0.00702	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCL5—atopic dermatitis	4.62e-05	0.00688	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GLB1—atopic dermatitis	4.46e-05	0.00664	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL22—atopic dermatitis	4.38e-05	0.00653	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	4.35e-05	0.00648	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	4.33e-05	0.00645	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCR3—atopic dermatitis	4.29e-05	0.00639	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ADSL—atopic dermatitis	4.27e-05	0.00636	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	4.21e-05	0.00627	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCR5—atopic dermatitis	4.16e-05	0.0062	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL6—atopic dermatitis	4.05e-05	0.00603	CbGpPWpGaD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	3.92e-05	0.00584	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL27—atopic dermatitis	3.91e-05	0.00582	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR3—atopic dermatitis	3.9e-05	0.0058	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—TAC1—atopic dermatitis	3.83e-05	0.0057	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—NPS—atopic dermatitis	3.83e-05	0.0057	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCR3—atopic dermatitis	3.75e-05	0.00559	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—PPARA—atopic dermatitis	3.58e-05	0.00533	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL5—atopic dermatitis	3.56e-05	0.0053	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—atopic dermatitis	3.53e-05	0.00526	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL17—atopic dermatitis	3.5e-05	0.00522	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	3.5e-05	0.00522	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—TAC1—atopic dermatitis	3.47e-05	0.00517	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—NPS—atopic dermatitis	3.47e-05	0.00517	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCR3—atopic dermatitis	3.41e-05	0.00507	CbGpPWpGaD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	3.35e-05	0.00499	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.3e-05	0.00492	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.25e-05	0.00484	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL5—atopic dermatitis	3.23e-05	0.00481	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	3.16e-05	0.0047	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KIF3A—atopic dermatitis	3.12e-05	0.00465	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL10—atopic dermatitis	3.03e-05	0.00452	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.96e-05	0.00441	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL6—atopic dermatitis	2.85e-05	0.00424	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CMA1—atopic dermatitis	2.82e-05	0.00421	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL11—atopic dermatitis	2.82e-05	0.00421	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL10—atopic dermatitis	2.75e-05	0.0041	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT6—atopic dermatitis	2.66e-05	0.00395	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCL5—atopic dermatitis	2.61e-05	0.00389	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.59e-05	0.00385	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CXCL8—atopic dermatitis	2.52e-05	0.00375	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.51e-05	0.00373	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GLB1—atopic dermatitis	2.48e-05	0.00369	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.41e-05	0.0036	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	2.41e-05	0.00359	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ADSL—atopic dermatitis	2.38e-05	0.00354	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL5—atopic dermatitis	2.37e-05	0.00353	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	2.37e-05	0.00352	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCR5—atopic dermatitis	2.35e-05	0.0035	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR3—atopic dermatitis	2.3e-05	0.00343	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR5—atopic dermatitis	2.14e-05	0.00318	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	2.11e-05	0.00314	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NPS—atopic dermatitis	2.05e-05	0.00306	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TAC1—atopic dermatitis	2.05e-05	0.00306	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCR3—atopic dermatitis	2.01e-05	0.003	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL5—atopic dermatitis	1.91e-05	0.00284	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.81e-05	0.00269	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	1.79e-05	0.00266	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL10—atopic dermatitis	1.63e-05	0.00242	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	1.59e-05	0.00237	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	1.59e-05	0.00236	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	1.53e-05	0.00228	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PPARA—atopic dermatitis	1.45e-05	0.00215	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL8—atopic dermatitis	1.42e-05	0.00212	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL5—atopic dermatitis	1.4e-05	0.00209	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2—atopic dermatitis	1.36e-05	0.00202	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GLB1—atopic dermatitis	1.32e-05	0.00196	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NGF—atopic dermatitis	1.3e-05	0.00193	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—atopic dermatitis	1.29e-05	0.00192	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.27e-05	0.00189	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ADSL—atopic dermatitis	1.26e-05	0.00188	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR5—atopic dermatitis	1.26e-05	0.00188	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	1.24e-05	0.00184	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—atopic dermatitis	1.23e-05	0.00184	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	1.16e-05	0.00172	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.16e-05	0.00172	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.08e-05	0.00162	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GLB1—atopic dermatitis	1.08e-05	0.0016	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NFKBIA—atopic dermatitis	1.07e-05	0.00159	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ADSL—atopic dermatitis	1.03e-05	0.00153	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.61e-06	0.00143	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PPARA—atopic dermatitis	8.05e-06	0.0012	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.84e-06	0.00117	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—atopic dermatitis	7.63e-06	0.00114	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—atopic dermatitis	7.29e-06	0.00109	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—atopic dermatitis	7.25e-06	0.00108	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAPK8—atopic dermatitis	6.71e-06	0.000999	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GLB1—atopic dermatitis	5.65e-06	0.000842	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ADSL—atopic dermatitis	5.42e-06	0.000807	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GLB1—atopic dermatitis	4.83e-06	0.000719	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ADSL—atopic dermatitis	4.63e-06	0.00069	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—atopic dermatitis	4.29e-06	0.000638	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPARA—atopic dermatitis	4.28e-06	0.000637	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.12e-06	0.000613	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.73e-06	0.000555	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.57e-06	0.000532	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.52e-06	0.000524	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPARA—atopic dermatitis	3.49e-06	0.00052	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.83e-06	0.000273	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.57e-06	0.000233	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.21e-06	0.00018	CbGpPWpGaD
